Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease

Ryosuke Saigusa,Payel Roy,Antoine Freuchet,Rishab Gulati,Yanal Ghosheh,Sujit Silas Armstrong Suthahar,Christopher P. Durant,David B. Hanna,William B. Kiosses,Marco Orecchioni,Lai Wen,Runpei Wu,Mark H. Kuniholm,Alan L. Landay,Kathryn Anastos,Phyllis C. Tien,Stephen J. Gange,Seble Kassaye,Jenifer Vallejo,Catherine C. Hedrick,William W. Kwok,Alessandro Sette,Howard N. Hodis,Robert C. Kaplan,Klaus Ley
DOI: https://doi.org/10.1038/s44161-022-00063-3
2022-05-13
Nature Cardiovascular Research
Abstract:Nature Cardiovascular Research, Published online: 12 May 2022; doi:10.1038/s44161-022-00063-3 Atherosclerosis is accompanied by an autoimmune response that includes CD4 T cells recognizing epitopes in apolipoprotein B (APOB). Saigusa et al. analyzed the transcriptomes and T cell receptors of APOB-specific CD4 T cells by single-cell RNA sequencing using MHC-II tetramers in women with atherosclerosis, and showed that APOB-specific regulatory T cells switch to a more memory-like phenotype in atherosclerosis.
What problem does this paper attempt to address?